Conjunctivitis (known as ‘pink eye’) is the infection or inflammation of the conjunctiva—the mucous membrane that covers the eye’s outer surface. In the United States, this uncomfortable ophthalmic condition affects an estimated 6 million people annually, accounting for one percent of all primary care visits.
Alembic Pharmaceuticals share price rose 3.5 percent intraday on April 20 after the company received tentative USFDA approval for its drug Alcaftadine Ophthalmic Solution, used in the prevention of itching associated with allergic conjunctivitis.
The U.S. FDA compiles a list of off-patent drugs without an approved generic to encourage the development of copycats. Now, the Chinese authorities are rolling out a similar initiative, only with some extra incentives.
List of New Paragraph IV Certifications as of Aug 21, 2018